Alpha Tau Medical Ltd.DRTSNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +0.61% | +0.61% | +1.06% | +15.00% | +19.82% |
| Weighted Average Shares Diluted Growth | +0.61% | +0.61% | +1.06% | +15.00% | +21.98% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +2.02% | +1647.37% | +267.74% | +129.13% | -100.00% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -15.00% | -19.73% | -21.00% | +15.52% | +15.39% |
| Book Value per Share Growth | -23.24% | -26.26% | -29.51% | +1.76% | -6.70% |
| Debt Growth | +107.62% | -5.57% | -5.01% | +6.02% | +7.46% |
| R&D Expense Growth | -7.49% | +0.57% | +11.20% | +2.13% | +34.57% |
| SG&A Expenses Growth | -5.99% | +11.74% | +8.20% | +20.48% | +14.45% |